bioAffinity Technologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIAF and other ETFs, options, and stocks.About BIAF
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells.
CEOMaria Zannes
CEOMaria Zannes
Employees57
Employees57
HeadquartersSan Antonio, Texas
HeadquartersSan Antonio, Texas
Founded2014
Founded2014
Employees57
Employees57
BIAF Key Statistics
Market cap6.18M
Market cap6.18M
Price-Earnings ratio-0.31
Price-Earnings ratio-0.31
Dividend yield—
Dividend yield—
Average volume4.48M
Average volume4.48M
High today$0.3597
High today$0.3597
Low today$0.20
Low today$0.20
Open price$0.2096
Open price$0.2096
Volume20.08M
Volume20.08M
52 Week high$2.99
52 Week high$2.99
52 Week low$0.1639
52 Week low$0.1639
People also own
Based on the portfolios of people who own BIAF. This list is generated using Robinhood data, and it’s not a recommendation.